Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Cryo Cell International (CCEL) Shares Issued (2017 - 2024)

Cryo Cell International's Shares Issued history spans 11 years, with the latest figure at $75400.0 for Q4 2024.

  • Quarterly results put Shares Issued at $75400.0 for Q4 2024, changed N/A from a year ago — trailing twelve months through Nov 2025 was $75400.0 (changed 0.0% YoY), and the annual figure for FY2025 was $23101.0, down 69.76%.
  • Shares Issued for Q4 2024 was $75400.0 at Cryo Cell International, down from $519274.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $874668.0 in Q2 2021 to a low of $32000.0 in Q1 2022.
  • The 4-year median for Shares Issued is $191622.0 (2021), against an average of $277727.3.
  • The sharpest move saw Shares Issued soared 619.3% in 2020, then plummeted 83.3% in 2022.
  • Year by year, Shares Issued stood at $41000.0 in 2020, then soared by 412.5% to $210127.0 in 2021, then soared by 147.12% to $519274.0 in 2022, then tumbled by 85.48% to $75400.0 in 2024.
  • According to Business Quant data, Shares Issued over the past three periods came in at $75400.0, $519274.0, and $32000.0 for Q4 2024, Q3 2022, and Q1 2022 respectively.